Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kristin A. Kantautas
Observed names:
K.A. Kantautas,
Kantautas, Kristin A.,
Kristin A Kantautas
ORCID:
0009-0003-2350-3073
Observed ORCID:
0009-0003-2350-3073
OpenAlex ID:
A5088264113
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
2022
·
Sandra Brasil
, Mariateresa Allocca
, et al.
·
International Journal of Molecular Sciences
·
20
PDF
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community
2024
·
Pedro Granjo
, Carlota Pascoal
, et al.
·
Orphanet Journal of Rare Diseases
·
10
N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts
2024
·
Kishore Garapati
, Wasantha Ranatunga
, et al.
·
Glycobiology
·
8
Repurposing the HMG-CoA Reductase Inhibitor Atorvastatin for SRD5A3-CDG
2026
·
Hiba Daghar
, Seul Kee Byeon
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Industrializing yeast as a drug repurposing platform for inherited metabolic diseases
2024
·
Mathuravani A. Thevandavakkam
, Natalie E. Long
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
Repurposing the HMG-CoA reductase inhibitor atorvastatin for SRD5A3-congenital disorder of glycosylation
2026
·
Hiba Daghar
, Seul Kee Byeon
, et al.
·
Communications Medicine
PDF
DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment
2026
·
I.J.J. Muffels
, K.A. Kantautas
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
13
Citation count:
40
H-index:
3
I10-index:
2
Year
Topic
Type
